drugset / Trial / NCT01409122

Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects

NCT01409122

Phase 1 Completed 42 enrolled Aires Pharmaceuticals, Inc.
RandomizedSingle-groupDouble-blindTreatment

Summary

This is a four-part study of the safety, tolerability, and PK profile of sodium nitrite inhalation solution (AIR001) of ascending multiple doses (Part A) and of escalating doses with steady-state sildenafil (Part B) to healthy male and female subjects, as well as assessment of the safety and tolerability of multiple doses of AIR001 to patients with pulmonary arterial hypertension (part C) with a single dose PK study of AIR001 utilizing three different nebulizers (Part D).

Timeline

Start
2011-07
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Nitrite Small molecule 15 mg Inhaled
Subject Sodium Nitrite Small molecule 45 mg Inhaled
Subject Sodium Nitrite Small molecule 90 mg Inhaled
Subject Sodium Nitrite Small molecule 120 mg Inhaled
Background Sildenafil Unknown 20 mg Oral